Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice
- 1 October 2006
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 16 (9-10) , 591-602
- https://doi.org/10.1016/j.nmd.2006.06.011
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The role of neutrophils in injury and repair following muscle stretchJournal of Anatomy, 2006
- Persistent and improved functional gain in mdx dystrophic mice after treatment with L‐arginine and deflazacortThe FASEB Journal, 2006
- Silencing TNFα activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in miceCell and tissue research, 2005
- A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx MiceThe American Journal of Pathology, 2005
- Prednisolone‐induced changes in dystrophic skeletal muscleThe FASEB Journal, 2005
- Inflammatory processes in muscle injury and repairAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscleNeuromuscular Disorders, 2004
- Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosisThe FASEB Journal, 2004
- Deferoxamine reduces and nitric oxide synthase inhibition increases neutrophil-mediated myotube injuryCell and tissue research, 2003
- Helper (CD4+) and Cytotoxic (CD8+) T Cells Promote the Pathology of Dystrophin-Deficient MuscleClinical Immunology, 2001